A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Gastric Cancer Stage III Clinical Trial

Official title:
A Randomized Phase III Study Comparing POF (Paclitaxel/Oxaliplatin/Leucovorin/5-FU) With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Status Recruiting

Clinical Trial Summary

FNF-014 is a randomised, open-label, multicentre, parallel-group, phase 3 study in China to prove superiority of POF over S-1/docetaxel in postoperative adjuvant setting for pStage III gastric adenocarcinoma (including adenocarcinoma of the gastrooesophageal junction).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03788226
Study type	Interventional
Source	Fujian Cancer Hospital
Contact	Rongbo Lin
Phone	13705919382
Email	rongbo_lin@163.com
Status	Recruiting
Phase	Phase 3
Start date	February 1, 2019
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04515615` - Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)	Phase 2
Recruiting	`NCT04119622` - Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer	Phase 2
Recruiting	`NCT02969148` - Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer	N/A
Completed	`NCT03550482` - Oncoxin® and Quality of Life in Cancer Patients	Phase 4
Recruiting	`NCT06342427` - Stomach Cancer Exosome-based Detection
Recruiting	`NCT06042998` - A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer	N/A
Recruiting	`NCT04152889` - A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer	Phase 2